Polymorphisms of CCL3L1/CCR5 Genes and Recurrence of Hepatitis B in Liver Transplant Recipients

Hong Li,Hai-Yang Xie,Lin Zhou,Wei-Lin Wang,Ting-Bo Liang,Min Zhang,Shu-Sen Zheng
DOI: https://doi.org/10.1016/s1499-3872(11)60101-x
IF: 3.355
2011-01-01
Hepatobiliary & Pancreatic Diseases International
Abstract:BACKGROUND: The genetic diversity of chemokines and chemokine receptors has been associated with the outcome of hepatitis B virus infection. The aim of this study was to evaluate whether the copy number variation in the CCL3L1 gene and the polymorphisms of CCR5A32 and CCR5-2459A -> G (rs1799987) are associated with recurrent hepatitis B in liver transplantation for hepatitis B virus infection-related end-stage liver disease.METHODS: A total of 185 transplant recipients were enrolled in this study. The genomic DNA was extracted from whole blood, the copy number of the CCL3L1 gene was determined by a quantitative real-time PCR based assay, CCR5A32 was detected by a sizing PCR method, and a single-nucleotide polymorphism in CCR5-2459 was detected by restriction fragment length polymorphism PCR.RESULTS: No CCR5A32 mutation was detected in any of the individuals from China. Neither copy number variation nor polymorphism in CCR5-2459 was associated with post-transplant re-infection with hepatitis B virus. However, patients with fewer copies (< 4) of the CCL3L1 gene compared with the population median in combination with the CCR5G allele had a significantly higher risk for recurrent hepatitis B (odds ratio =1.93, 95% CI: 1.00-3.69; P=0.047).CONCLUSION: Patients possessing the compound decreased functional genotype of both CCL3L1 and CCR5 genes might be more likely to have recurrence of hepatitis B after transplantation.
What problem does this paper attempt to address?